We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current KNE market cap is 15.6M. The company's latest EPS is CAD -0.0312 and P/E is -3.85.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 506k | 1.69M | 1.34M | 1.61M | 2.67M |
| Operating Income | -3.18M | -3.59M | -4.23M | -4.88M | -3.36M |
| Net Income | -3.26M | -960k | -3.98M | -4.61M | -3.89M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.56M | 2.76M | 5.04M | 6.13M | 5.62M |
| Total Liabilities | 2.54M | 1.92M | 3.96M | 7.7M | 9.76M |
| Total Equity | -985k | 837k | 1.07M | -1.57M | -4.14M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.85M | -955k | -3.94M | -2.29M | -3.04M |
| Investing | -146k | -97k | -166k | -374k | -108k |
| Financing | 1.1M | 1.81M | 4.28M | 2.81M | 3.1M |
| Market Cap | 15.6M |
| Price to Earnings Ratio | -3.85 |
| Price to Sales Ratio | 5.61 |
| Price to Cash Ratio | 13.64 |
| Price to Book Ratio | -3.62 |
| Dividend Yield | - |
| Shares Outstanding | 124.83M |
| Average Volume (1 week) | 80.14k |
| Average Volume (1 Month) | 433.48k |
| 52 Week Change | 8.70% |
| 52 Week High | 0.17 |
| 52 Week Low | 0.05 |
| Spread (Intraday) | 0.01 (7.14%) |
| Company Name | Kane Biotech Inc |
| Address |
290-100 innovation drive winnipeg, manitoba R3T 6G2 |
| Website | https://www.kanebiotech.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
